{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:27Z","timestamp":1792791567055,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB07\/09\/0033"],"award-info":[{"award-number":["CB07\/09\/0033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS-510"],"award-info":[{"award-number":["CTS-510"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111183","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:38:11Z","timestamp":1788950291000},"page":"111183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Locus Coeruleus mediates the pharmacological effects of 2-Pentadecyl-2-oxazoline in a mouse model of neuropathic pain"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-0054","authenticated-orcid":false,"given":"Flavia","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8447-928X","authenticated-orcid":false,"given":"Meritxell","family":"Llorca-Torralba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Berrocoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S1461145711001842","article-title":"Active behaviours produced by antidepressants and opioids in the mouse tail suspension test","volume":"16","author":"Berrocoso","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-020-00724-z","article-title":"2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors","volume":"14","author":"Boccella","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2026.111183_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2020.00091","article-title":"Treatment with 2-Pentadecyl-2-Oxazoline restores mild traumatic brain injury-induced sensorial and neuropsychiatric dysfunctions","volume":"11","author":"Boccella","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib5","doi-asserted-by":"crossref","first-page":"14e1","DOI":"10.1016\/j.pain.2005.10.036","article-title":"Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse","volume":"122","author":"Bourquin","year":"2006","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111183_bib6","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3390\/ijms22083927","article-title":"PEA-OXA mitigates oxaliplatin-induced painful neuropathy through NF-\u03baB\/Nrf-2 axis","volume":"22","author":"Campolo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111183_bib7","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acs.biochem.0c00629","article-title":"Natural products for the treatment of pain: chemistry and pharmacology of salvinorin A, mitragynine, and collybolide","volume":"60","author":"Chakraborty","year":"2021","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111183_bib8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1523\/JNEUROSCI.1433-17.2018","article-title":"Altered baseline and nicotine-mediated behavioral and cholinergic profiles in ChAT-Cre mouse lines","volume":"38","author":"Chen","year":"2018","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111183_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpsgos.2024.100388","article-title":"A systematic review and meta-analysis of Anxiety- and depressive-like behaviors in rodent models of neuropathic pain","volume":"4","author":"De La Rosa","year":"2024","journal-title":"Biological Psychiatry Global Open Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2026.111183_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111183_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12974-018-1303-5","article-title":"Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush","volume":"15","author":"Gugliandolo","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111183_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/ALN.0b013e31818dac9c","article-title":"Gabapentin acts within the locus coeruleus to alleviate neuropathic pain","volume":"109","author":"Hayashida","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2026.111183_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29808","article-title":"Functional dichotomy in spinal- vs prefrontal-projecting locus coeruleus modules splits descending noradrenergic analgesia from ascending aversion and anxiety in rats","volume":"6","author":"Hirschberg","year":"2017","journal-title":"eLife"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111183_bib16","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.pain.2013.05.010","article-title":"Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury","volume":"154","author":"Hughes","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111183_bib17","first-page":"D1171","volume":"vol. 43","year":"2015"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111183_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0b013e3283311e13","article-title":"Pharmacology and treatment of neuropathic pains","volume":"22","author":"Jensen","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111183_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuroscience.2016.05.057","article-title":"Noradrenergic Locus Coeruleus pathways in pain modulation","volume":"338","author":"Llorca-Torralba","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/brain\/awab239","article-title":"Pain and depression comorbidity causes asymmetric plasticity in the locus coeruleus neurons","volume":"145","author":"Llorca-Torralba","year":"2022","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111183_bib21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.biopsych.2019.02.018","article-title":"Chemogenetic silencing of the locus coeruleus\u2013basolateral Amygdala pathway abolishes pain-induced anxiety and enhanced aversive learning in rats","volume":"85","author":"Llorca-Torralba","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111183_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0006-8993(03)02293-5","article-title":"Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice","volume":"970","author":"Ma","year":"2003","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13293-023-00550-7","article-title":"Sexual differences in locus coeruleus neurons and related behavior in C57BL\/6J mice","volume":"14","author":"Mariscal","year":"2023","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.neuropharm.2026.111183_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000003927","article-title":"Sex differences in the impact of nerve injury on locus coeruleus function and behaviour in mice","author":"Mariscal","year":"2026","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111183_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2010.02.043","article-title":"The hyperalgesic effects induced by the injection of angiotensin II into the caudal ventrolateral medulla are mediated by the pontine A5 noradrenergic cell group","volume":"1325","author":"Marques-Lopes","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/ALN.0000000000000749","article-title":"Increased noradrenergic neurotransmission to a pain facilitatory area of the brain is implicated in facilitation of chronic pain","volume":"123","author":"Martins","year":"2015","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuron.2015.07.002","article-title":"CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety","volume":"87","author":"McCall","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111183_bib28","article-title":"Mu opioid receptors gate the locus coeruleus pain generator","author":"Norris","year":"2024","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111183_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s11011-017-0031-3","article-title":"Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours","volume":"32","author":"Onaolapo","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2026.111183_bib30","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2019"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111183_bib31","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/bph.12645","article-title":"Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain","volume":"171","author":"Percie Du Sert","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70401","article-title":"Uncovering hidden phenotypes in NEX \u2010cre mice: behavioral and cellular alterations demand re\u2010evaluation of a widely used transgenic line","volume":"170","author":"Renken","year":"2026","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111183_bib33","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.celrep.2016.05.034","article-title":"Recombinase-dependent mouse lines for chemogenetic activation of genetically defined cell types","volume":"15","author":"Sciolino","year":"2016","journal-title":"Cell Rep."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2026.111183_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jad.2007.01.015","article-title":"Depression\u2013anxiety relationships with chronic physical conditions: results from the world mental health surveys","volume":"103","author":"Scott","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bjp.2018.11.006","article-title":"Central nervous system and analgesic profiles of Lippia genus","volume":"29","author":"Siqueira-Lima","year":"2019","journal-title":"Revista Brasileira de Farmacognosia"},{"key":"10.1016\/j.neuropharm.2026.111183_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.839715","article-title":"The absence of Caspase-8 in the dopaminergic system leads to mild autism-like behavior","volume":"10","author":"Su\u00e1rez-Pereira","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111183_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12974-023-02865-z","article-title":"Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis","volume":"20","author":"Torrillas-de La Cal","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111183_bib38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Van Hecke","year":"2014","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111183_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0149-7634(98)00027-X","article-title":"Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety","volume":"23","author":"Weiss","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib40","article-title":"Oral morphine for cancer pain","volume":"2021","author":"Wiffen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111183_bib41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1212\/CON.0000000000000462","article-title":"Neuropathic pain","volume":"23","author":"Zilliox","year":"2017","journal-title":"Continuum: Lifelong Learning in Neurology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111183_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0304-3959(03)00261-6","article-title":"Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells","volume":"105","author":"Zuo","year":"2003","journal-title":"Pain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:57:43Z","timestamp":1792789063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0028390826003588"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111183","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locus Coeruleus mediates the pharmacological effects of 2-Pentadecyl-2-oxazoline in a mouse model of neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111183"}}